The use of statins appears to benefit patients hospitalized with COVID-19, according to the findings of a retrospective study conducted in Hubei Province, China.
A strong association between statin use and incidence of eczema, especially in older patient populations, suggests that assessment for predisposing factors are in order.
Hypertension and dyslipidemia display a correlation with rosacea, although ischemic heart disease, stroke, and diabetes do not.
Elevated lipoprotein(a) levels was not found to be caused by FH, but may help with clinical recognition of genetic FH.
Nexlizet (bempedoic acid and ezetimibe; Esperion) is now available for use as an adjunct to diet and maximally tolerated statin therapy for the treatment of adults with heterozygous familial hypercholesterolemia or established atherosclerotic cardiovascular disease who require additional lowering of LDL-C.
The addition of bile acid sequestrants to statin therapy may further reduce LDL-c in patients intolerant to maximal statin dosage.
Fasting plasma of apolipoprotein B48 concentrations in adolescents were found to beassociated with measures of adiposity and features of the metabolic syndrome in adolescents.
Treatment with statins for cardiovascular risk reduction is associated with higher levels of insulin resistance in older community-dwelling adults.
A scientific statement from the National Lipid Association outlines the implications of genetic testing in patients with dyslipidemia.
Greater capacities in 3 key measures of high-density lipoprotein functionality were found to be associated with a reduced risk for cardiovascular disease.